The cities of Bluffdale, Draper, Riverton, and Vineyard are sponsoring COVID-19 antibody testing for city residents through a privately administered COVID-19 screening program. The goal of the program is to detect antibodies related to COVID-19. If individuals think they have been exposed, or just want to know if they have had COVID-19, they are invited to come and take a test.
Mayors from the participating communities released this joint statement about the project:
“We believe a central component to beating COVID-19 is to test our residents. We need to know our true infection rate so we can take actions to limit the spread, conduct contact tracing, and make future data-driven public policy decisions. We invite all our residents to consider being tested for COVID-19 antibodies as we continue to battle this virus.”
Any residents interested in being tested may sign up for an appointment online at rapidscreen.as.me, on a first-come, first-served basis. The screening costs $69.99 (may be reimbursable by health insurance plans), payable by credit or debit card at the time of booking. Appointments are booked in 30-minute increments throughout each day and conducted in a drive-thru setting. Results are provided within 15-20 minutes. The testing schedule is as follows:
- Wednesday, May 20 – Draper
- Thursday, May 21 – Riverton
- Tuesday, May 26 – Draper
- Thursday, May 28 – Bluffdale
- Friday, May 29 – Vineyard
Testing will be conducted by Utah-based RapidScreen Solutions, LLC (RSS) using testing kits manufactured in the United States from New York-based Chembio. The test is a lateral flow blood test that has Emergency Use Authorization (EUA) from the FDA. Using a finger-stick test, a small (drop) blood sample is taken from a finger and placed on a test strip to detect two different antibodies in the subject’s blood: IgM and IgG. Positive results indicate the likelihood of a current or past COVID-19 infection.